Ironwood Pharmaceuticals (IRWD) Other financing activities (2010 - 2025)

Ironwood Pharmaceuticals (IRWD) has 16 years of Other financing activities data on file, last reported at $122000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities fell 39.9% year-over-year to $122000.0; the trailing twelve-month figure through Dec 2025 stood at $216000.0 (down 98.04% YoY), and the FY2025 full-year result was $216000.0, down 98.04% from the prior year.
• Other financing activities climbed to $122000.0 in Q4 2025, from $88000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $10.1 million in Q1 2024 to a low of $6000.0 in Q1 2025.
• A 5-year average of $2.6 million and a median of $1.5 million in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities jumped 820.0% in 2021 and plunged 99.94% in 2025, its largest moves.
• Tracing IRWD's Other financing activities over 5 years: stood at $5.5 million in 2021, then plunged by 49.39% to $2.8 million in 2022, then plunged by 64.43% to $998000.0 in 2023, then tumbled by 79.66% to $203000.0 in 2024, then tumbled by 39.9% to $122000.0 in 2025.
• Business Quant data shows IRWD's Other financing activities at $122000.0 in Q4 2025, $88000.0 in Q2 2025, and $6000.0 in Q1 2025.